Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
基于纳米纤维的组合免疫调节化合物的递送以最大程度地减少感染并促进伤口愈合
基本信息
- 批准号:10653967
- 负责人:
- 金额:$ 31.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAnti-Infective AgentsAntibiotic ResistanceAntibioticsAwardBacteriaCell Culture TechniquesCell ProliferationCellsCessation of lifeClinicalCollagenDataDepositionDevelopmentESKAPE pathogensEncapsulatedEngraftmentFoundationsFundingGasesGenesGoalsGrantHealth Care CostsHumanImmuneImmune responseImmune systemImmunityInfectionInfection preventionInflammationInflammatoryInfrastructureInpatientsInterventionInvestmentsKnowledgeLifeMass Spectrum AnalysisMeasuresMechanicsMembraneMesenchymalMethodsMicroRNAsModelingMorphologyMulti-Drug ResistanceMusNanofiber ScaffoldNatural ImmunityOperating RoomsOperative Surgical ProceduresPaperPatientsPeptidesPlayPostoperative PeriodPrimatesProductivityPropertyProteinsProteomicsPublishingResistance developmentSkinSpeedStaphylococcus aureusSterile coveringsSterilityStructureSurgical Wound InfectionSurgical incisionsTechniquesTestingTherapeuticTopical applicationTransfectionTransgenic MiceUnited StatesVirulenceVitamin DWorkWound InfectionWound modelsantimicrobialbiomaterial compatibilitycathelicidin antimicrobial peptidecombat injuryconventional therapycostcytokinecytotoxicityeffective therapyexosomehealinghealthcare-associated infectionsimmune cell infiltrateimmunoregulationimprovedinnovationkeratinocytemiRNA expression profilingmigrationmouse modelnanofibernanomaterialsneovascularizationnext generationnovelnovel strategiesnovel therapeuticsoverexpressionpathogenpreclinical studypreventreadmission ratesresponserisk minimizationscaffoldskin woundtwo-dimensionalwound dressingwound healing
项目摘要
ABSRTACT
Despite major efforts to keep operating rooms sterile, surgical site infections (SSIs) remain a serious and stub-
born problem, killing up to 8,200 patients a year in the U.S. Our long-term goal is to develop novel therapies that
effectively minimize risk of SSIs and promote wound healing. During the previous funding cycles of this award,
we have demonstrated that i) successful encapsulation and sustained release of vitamin D and other immuno-
modulating compounds induced higher cathelicidin antimicrobial peptide (CAMP) gene and protein (hCAP18/LL-
37) levels in immune cells and keratinocytes in cell culture, a human CAMP transgenic mouse wound model and
human skin explants; ii) topical vitamin D increased killing of Staphylococcus aureus in a skin wound-infection
model using our human CAMP transgenic mouse; and iii) exosomes secreted from immune cells treated with
vitamin D contained higher levels of hCAP18/LL-37. Furthermore, we developed a novel gas-foaming expansion
technique to fabricate improved 3D nanofiber scaffolds eluting vitamin D that promoted immune cell infiltration,
induced hCAP18/LL-37, decreased inflammation, and promoted neovascularization and collagen deposition in
human immune system-engrafted mice. Building on these findings, and our preliminary data, the goal of our
proposal focuses on the development of nanofiber-based dressings for enhancing innate immunity. Our over-
arching hypothesis is that co-encapsulating immunomodulating compounds with exosomes secreted from
treated immune cells in 3D nanofiber scaffolds will synergistically enhance protection against SSIs and promote
wound healing better than either component alone. To accomplish this, there are three specific aims: 1) Demon-
strate efficient encapsulation and elution of immunomodulating compounds from our improved 3D nanofiber
scaffolds; 2) Determine the antimicrobial and wound-healing efficacy of exosomes derived from primed or human
CAMP transfected immune cells; and 3) Demonstrate the efficacy of immunomodulating compounds and exo-
somes - co-incorporated 3D nanofiber scaffolds to promote healing and prevent infection in our humanized trans-
genic mouse model and ex vivo human skin explants. Building on work from our prior grant, we expect successful
completion of the aims in this renewal will lay a strong foundation for developing the next generation of novel
therapeutic anti-infective wound dressings that could greatly speed healing, reduce rates of SSIs and minimize
development of antibiotic resistance. We also expect these dressings could serve as effective treatments for
traumatic and combat-related injuries.
ABSRTA
尽管尽了很大努力保持手术室的无菌,但手术部位感染(SSI)仍然是一个严重和残存的问题。
天生的问题,在美国每年导致多达8200名患者死亡。我们的长期目标是开发新的疗法,
有效地将SSI的风险降至最低,促进伤口愈合。在本奖项的前几个供资周期中,
我们已经证明:1)维生素D和其他免疫球蛋白的成功包裹和持续释放。
调节化合物诱导更高水平的中草药抗菌肽(CAMP)基因和蛋白(hCAP18/L1-
37)免疫细胞和角质形成细胞在细胞培养、人cAMP转基因小鼠创伤模型和
人体皮肤移植;ii)局部应用维生素D增加皮肤伤口感染时对金黄色葡萄球菌的杀灭作用
使用我们的人cAMP转基因小鼠的模型;以及iii)从免疫细胞分泌的外体
维生素D含有较高水平的hCAP18/LL-37。此外,我们还开发了一种新型的气体发泡膨胀剂
制造改进的3D纳米纤维支架的技术,该支架洗脱促进免疫细胞渗透的维生素D,
诱导hCAP18/LL-37,减轻炎症反应,促进新生血管形成和胶原沉积
植入人类免疫系统的小鼠。基于这些发现和我们的初步数据,我们的目标是
提案的重点是开发以纳米纤维为基础的敷料,以增强天然免疫力。我们结束了-
ARCHING假说是将免疫调节化合物与外切体共包裹在一起
3D纳米纤维支架中经过处理的免疫细胞将协同增强对SSI的保护并促进
伤口愈合比单独使用任何一个组件都要好。要做到这一点,有三个具体的目标:1)恶魔-
高效包埋和洗脱改良3D纳米纤维中的免疫调节化合物
支架;2)测定来自预涂或人类来源的外切体的抗菌和伤口愈合效果
CAMP转染的免疫细胞;3)证明免疫调节化合物和外源基因的有效性。
SOMES-共包含3D纳米纤维支架,以促进愈合和防止感染在我们的人源化反式
基因小鼠模型和体外人皮肤移植。在我们之前拨款的基础上,我们预计会取得成功
这一更新目标的完成将为下一代小说的发展奠定坚实的基础
治疗性抗感染创面敷料,可以大大加快愈合速度,降低SSI的发生率,并将
抗生素耐药性的发展。我们还希望这些敷料可以有效地治疗
创伤和与战斗有关的伤害。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jingwei Xie其他文献
Jingwei Xie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jingwei Xie', 18)}}的其他基金
Multifunctional Intelligent Hierarchical Fibrous Biomaterials Integrated with Multimodal Biosensing and Feedback-Based Interventions for Healing Infected Chronic Wounds
多功能智能分层纤维生物材料与多模式生物传感和基于反馈的干预措施相结合,用于治愈感染的慢性伤口
- 批准号:
10861531 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair
增强基于工程心脏组织的心肌修复的策略
- 批准号:
10581419 - 财政年份:2023
- 资助金额:
$ 31.69万 - 项目类别:
A Novel High-Intensity Iontophoresis-Based Antibiotic Delivery Device for Efficacious Eradication of Chronic Wound Biofilms
一种新型高强度离子电渗疗法抗生素输送装置,可有效根除慢性伤口生物膜
- 批准号:
10433163 - 财政年份:2022
- 资助金额:
$ 31.69万 - 项目类别:
A Novel High-Intensity Iontophoresis-Based Antibiotic Delivery Device for Efficacious Eradication of Chronic Wound Biofilms
一种新型高强度离子电渗疗法抗生素输送装置,可有效根除慢性伤口生物膜
- 批准号:
10634602 - 财政年份:2022
- 资助金额:
$ 31.69万 - 项目类别:
Biomimetic and Injectable Highly Porous Nanofiber Microsphere-based Platform for Alveolar Bone Regeneration
用于牙槽骨再生的仿生和可注射高孔隙纳米纤维微球平台
- 批准号:
10641000 - 财政年份:2022
- 资助金额:
$ 31.69万 - 项目类别:
Engineering structural bone allografts for enhanced repair and reconstruction
工程结构同种异体骨移植以增强修复和重建
- 批准号:
9978190 - 财政年份:2020
- 资助金额:
$ 31.69万 - 项目类别:
Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
基于纳米纤维的组合免疫调节化合物的递送以最大程度地减少感染并促进伤口愈合
- 批准号:
10473866 - 财政年份:2017
- 资助金额:
$ 31.69万 - 项目类别:
Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
基于纳米纤维的组合免疫调节化合物的递送以最大程度地减少感染并促进伤口愈合
- 批准号:
10299094 - 财政年份:2017
- 资助金额:
$ 31.69万 - 项目类别:
Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
基于纳米纤维的组合免疫调节化合物的递送以最大程度地减少感染并促进伤口愈合
- 批准号:
10796228 - 财政年份:2017
- 资助金额:
$ 31.69万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.69万 - 项目类别:
Research Grant